Literature DB >> 18461012

Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic.

Maria F Gallo1, Lee Warner, Maurizio Macaluso, Katherine M Stone, Ilene Brill, Michael E Fleenor, Edward W Hook, Harland D Austin, Francis K Lee, André J Nahmias.   

Abstract

OBJECTIVES: To estimate the incidence of herpes simplex type 2 virus (HSV-2) infection, to identify risk factors for its acquisition, and to assess the protective effect of condoms. STUDY
DESIGN: Prospective study of 293 HSV-2 seronegative women, aged 18 to 35 years, attending a sexually transmitted disease clinic in Alabama from 1992 to 1995.
RESULTS: Incidence of HSV-2 infection was 20.5 per 100 woman-years [95% confidence interval (CI), 13.1-30.5]. Young women (18-20 years) had a significantly higher risk of incident HSV-2 infection [adjusted hazard ratio (HR), 2.8; 95% CI, 1.3-6.4] than older women. Women diagnosed with prevalent or incident bacterial vaginosis had a higher incidence of HSV-2 infection than those who were not so diagnosed (adjusted HR, 2.4; 95% CI, 1.1-5.6). No significant protective effect was observed for consistent (100%) condom use without breakage and slippage against HSV-2 acquisition (adjusted HR, 0.8; 95% CI, 0.2-2.3).
CONCLUSION: Acquisition of HSV-2 infection among study participants was higher than previous estimates for adult female sexually transmitted disease clinic attendees, and no protective effect for condoms was demonstrated. The high incidence of HSV-2 infection with its potential for adverse health consequences emphasizes the need for better prevention strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18461012     DOI: 10.1097/OLQ.0b013e31816fcaf8

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  14 in total

1.  Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents.

Authors:  Staci L Sudenga; Mirjam-Colette Kempf; Gerald McGwin; Craig M Wilson; Edward W Hook; Sadeep Shrestha
Journal:  Sex Transm Dis       Date:  2012-04       Impact factor: 2.830

Review 2.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

3.  Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium.

Authors:  Erica M Lokken; Jennifer E Balkus; James Kiarie; James P Hughes; Walter Jaoko; Patricia A Totten; R Scott McClelland; Lisa E Manhart
Journal:  Am J Epidemiol       Date:  2017-07-15       Impact factor: 4.897

4.  Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition.

Authors:  Jeffrey D Stanaway; Anna Wald; Emily T Martin; Sami L Gottlieb; Amalia S Magaret
Journal:  Sex Transm Dis       Date:  2012-05       Impact factor: 2.830

5.  Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women.

Authors:  R Scott McClelland; Jennifer E Balkus; Jeannette Lee; Omu Anzala; Joshua Kimani; Jane Schwebke; Vivian Bragg; Shelly Lensing; Lale Kavak
Journal:  J Infect Dis       Date:  2014-12-19       Impact factor: 5.226

6.  Socio-demographic and behavioral correlates of herpes simplex virus type 1 and 2 infections and co-infections among adults in the USA.

Authors:  Hind A Beydoun; Jessica Dail; Bethrand Ugwu; Adel Boueiz; May A Beydoun
Journal:  Int J Infect Dis       Date:  2010-04-24       Impact factor: 3.623

7.  Incidence of herpes simplex virus type 2 in young reproductive age women in Mysore, India.

Authors:  Purnima Madhivanan; Yea-Hung Chen; Karl Krupp; Anjali Arun; Jeffrey D Klausner; Arthur L Reingold
Journal:  Indian J Pathol Microbiol       Date:  2011 Jan-Mar       Impact factor: 0.740

8.  Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.

Authors:  David I Bernstein; Abbie R Bellamy; Edward W Hook; Myron J Levin; Anna Wald; Marian G Ewell; Peter A Wolff; Carolyn D Deal; Thomas C Heineman; Gary Dubin; Robert B Belshe
Journal:  Clin Infect Dis       Date:  2012-10-19       Impact factor: 9.079

9.  Vaginal microbiota and the use of probiotics.

Authors:  Sarah Cribby; Michelle Taylor; Gregor Reid
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-03-29

10.  Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.

Authors:  Amalia S Magaret; Andrew Mujugira; James P Hughes; Jairam Lingappa; Elizabeth A Bukusi; Guy DeBruyn; Sinead Delany-Moretlwe; Kenneth H Fife; Glenda E Gray; Saidi Kapiga; Etienne Karita; Nelly R Mugo; Helen Rees; Allan Ronald; Bellington Vwalika; Edwin Were; Connie Celum; Anna Wald
Journal:  Clin Infect Dis       Date:  2015-11-17       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.